NUCLEOLIN and bone marrow neoplasm: Of importance is the fact that the expression of cell surface NCL was demonstrated on NB cells derived from patients suffering with metastatic bone marrow tumor infiltration, both at recurrence and at onset, and on NB primary tumors masses, supporting NCL as a new marker and an useful cellular target molecule also in the clinical setting.